| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1079/PNS2002230 |
| P698 | PubMed publication ID | 12740065 |
| P50 | author | John C. Mathers | Q43191125 |
| Elizabeth A Williams | Q51762581 | ||
| P2093 | author name string | Jonathan M Coxhead | |
| P2860 | cites work | The Hallmarks of Cancer | Q221226 |
| Effects of short chain fatty acids on a new human colon carcinoma cell line (LIM1215). | Q24548152 | ||
| Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells | Q24563114 | ||
| The retinoblastoma protein and cell cycle control | Q27860722 | ||
| Molecular interactions on microarrays | Q28294836 | ||
| The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis | Q29616121 | ||
| Proteome analysis of butyrate-treated human colon cancer cells (HT-29). | Q31045932 | ||
| Proteomics: quantitative and physical mapping of cellular proteins | Q33586063 | ||
| Mutational analysis using oligonucleotide microarrays | Q33755554 | ||
| A comparison of selected mRNA and protein abundances in human liver | Q34064644 | ||
| p53 protein at the hub of cellular DNA damage response pathways through sequence-specific and non-sequence-specific DNA binding | Q34263254 | ||
| Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. | Q34290119 | ||
| Short chain fatty acids in human large intestine, portal, hepatic and venous blood | Q34529426 | ||
| The impact of chromatin in human cancer: linking DNA methylation to gene silencing | Q34739107 | ||
| Microarrays as cancer keys: an array of possibilities. | Q34739207 | ||
| Mechanisms and experimental and epidemiological evidence relating dietary fibre (non-starch polysaccharides) and starch to protection against large bowel cancer | Q37897782 | ||
| Effect of sodium butyrate on mammalian cells in culture: A review | Q38283893 | ||
| Genes modulated by histone acetylation as new effectors of butyrate activity | Q38299556 | ||
| Butyrate- but not TGFbeta1-induced apoptosis of colorectal adenoma cells is associated with increased expression of the differentiation markers E-cadherin and alkaline phosphatase. | Q40319429 | ||
| Modulation of angiogenesis-related proteins synthesis by sodium butyrate in colon cancer cell line HT29. | Q40731017 | ||
| Transcriptional response of a human colon adenocarcinoma cell line to sodium butyrate. | Q40789496 | ||
| p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents | Q40796687 | ||
| The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line | Q40891401 | ||
| Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression | Q40893919 | ||
| Butyrate mediates Caco-2 cell apoptosis via up-regulation of pro-apoptotic BAK and inducing caspase-3 mediated cleavage of poly-(ADP-ribose) polymerase (PARP). | Q40932353 | ||
| Sodium butyrate induces retinoblastoma protein dephosphorylation, p16 expression and growth arrest of colon cancer cells | Q40993622 | ||
| Proteasome-dependent regulation of p21WAF1/CIP1 expression | Q41158898 | ||
| Loss of APC protein expressed by human colonic epithelial cells and the appearance of a specific low-molecular-weight form is associated with apoptosis in vitro | Q41438315 | ||
| Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer | Q41526050 | ||
| Butyrate inhibits mouse fibroblasts at a control point in the G1 phase | Q41543541 | ||
| Effects of short-chain fatty acids on growth and differentiation of the human colon-cancer cell line HT29 | Q41603400 | ||
| Sodium butyrate enhances complement-mediated cell injury via down-regulation of decay-accelerating factor expression in colonic cancer cells | Q42517869 | ||
| Tributyrin, an oral butyrate analogue, induces apoptosis through the activation of caspase-3. | Q43696024 | ||
| Butyrate and the cytokine-induced alpha1-proteinase inhibitor release in intestinal epithelial cells. | Q43923370 | ||
| Novel mode of interference with nuclear factor of activated T-cells regulation in T-cells by the bacterial metabolite n-butyrate | Q43976228 | ||
| Butyrate strongly inhibits in vitro stimulated release of cytokines in blood. | Q43980803 | ||
| Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells | Q44219057 | ||
| The adenomatous polyposis coli protein and retinoblastoma protein are cleaved early in apoptosis and are potential substrates for caspases | Q50336582 | ||
| Concentration-dependent effects of sodium butyrate in Chinese hamster cells: cell-cycle progression, inner-histone acetylation, histone H1 dephosphorylation, and induction of an H1-like protein. | Q50749801 | ||
| Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model. | Q53453650 | ||
| Involvement of p21(Waf1/Cip1) and its cleavage by DEVD-caspase during apoptosis of colorectal cancer cells induced by butyrate | Q73295253 | ||
| Comparison of the effect of different short chain fatty acids on the growth and differentiation of human colonic carcinoma cell lines in vitro | Q73557602 | ||
| High-throughput polymorphism screening and genotyping with high-density oligonucleotide arrays | Q74618474 | ||
| A matter of life and cell death | Q77164675 | ||
| Cancer cell sensitization to fas-mediated apoptosis by sodium butyrate | Q77315588 | ||
| Expression profiling using cDNA microarrays | Q77895878 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 107-115 | |
| P577 | publication date | 2003-02-01 | |
| P1433 | published in | Proceedings of the Nutrition Society | Q15817594 |
| P1476 | title | Anti-cancer effects of butyrate: use of micro-array technology to investigate mechanisms | |
| P478 | volume | 62 |
| Q34974010 | A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis |
| Q57316214 | Aspirin, salicylates and cancer: report of a meeting at the Royal Society of Medicine, London, 23 November 2010 |
| Q92026537 | Association Between Dairy Product Consumption and Colorectal Cancer Risk in Adults: A Systematic Review and Meta-Analysis of Epidemiologic Studies |
| Q46240606 | Augmentation of tendon healing with butyric acid-impregnated sutures: biomechanical evaluation in a rabbit model |
| Q34406197 | Barley β-glucans-containing food enhances probiotic performances of beneficial bacteria |
| Q88170682 | Butyrate Inhibits Indices of Colorectal Carcinogenesis via Enhancing α-Ketoglutarate-Dependent DNA Demethylation of Mismatch Repair Genes |
| Q41927515 | Butyrate modulates bacterial adherence on LS174T human colorectal cells by stimulating mucin secretion and MAPK signaling pathway |
| Q21562371 | Butyrate-induced transcriptional changes in human colonic mucosa |
| Q56435752 | Chemoprevention in Lynch syndrome |
| Q39451538 | Chemopreventive effects of in vitro digested and fermented bread in human colon cells |
| Q51123805 | Construction and characterization of ack deleted mutant of Clostridium tyrobutyricum for enhanced butyric acid and hydrogen production. |
| Q58209584 | Continuous enzymatic interesterification of milkfat with soybean oil produces a highly spreadable product rich in polyunsaturated fatty acids |
| Q37591355 | Current progress on butyric acid production by fermentation |
| Q64059347 | Diet-induced metabolic changes of the human gut microbiome: importance of short-chain fatty acids, methylamines and indoles |
| Q39756970 | Differential antineoplastic effects of butyrate in cells with and without a functioning DNA mismatch repair |
| Q64979318 | Effects of Intestinal Microbial⁻Elaborated Butyrate on Oncogenic Signaling Pathways. |
| Q37607632 | Effects of supplementation with nondigestible carbohydrates on fecal calprotectin and on epigenetic regulation of SFRP1 expression in the large-bowel mucosa of healthy individuals |
| Q35646086 | Emerging diet-related surrogate end points for colorectal cancer: UK Food Standards Agency diet and colonic health workshop report |
| Q54331476 | Enzyme deactivation treatments did not decrease the beneficial role of oat food in intestinal microbiota and short-chain fatty acids: an in vivo study. |
| Q34460981 | Epigenetic control of aging |
| Q46335556 | Evaluation of novel histone deacetylase inhibitors as therapeutic agents for colorectal adenocarcinomas compared to established regimens with the histoculture drug response assay |
| Q90564385 | Fecal volatile organic compounds for early detection of colorectal cancer: where are we now? |
| Q43280645 | Fermented wheat aleurone inhibits growth and induces apoptosis in human HT29 colon adenocarcinoma cells |
| Q33705103 | Gene expression profiles of colonic mucosa in healthy young adult and senior dogs |
| Q55919832 | Health effects of resistant starch |
| Q37290063 | Hexosamine template. A platform for modulating gene expression and for sugar-based drug discovery |
| Q28586306 | Human gut microbiota and healthy aging: Recent developments and future prospective |
| Q37890253 | Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis |
| Q56095502 | Implications of butyrate and its derivatives for gut health and animal production |
| Q47372525 | In vitro fermentation of chewed mango and banana: particle size, starch and vascular fibre effects |
| Q37798946 | Induction of Epigenetic Alterations by Dietary and Other Environmental Factors |
| Q37349968 | Intake of dairy products and risk of colorectal neoplasia |
| Q43119859 | Intestinal tumours, colonic butyrate and sleep in exercised Min mice |
| Q46931476 | Involvement of glutathione/glutathione S-transferase antioxidant system in butyrate-inhibited vascular smooth muscle cell proliferation |
| Q38361952 | Is resistant starch protective against colorectal cancer via modulation of the WNT signalling pathway? |
| Q56435837 | Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial |
| Q34141652 | Prebiotic effects: metabolic and health benefits |
| Q46465937 | Production of butyric acid from glucose and xylose with immobilized cells of Clostridium tyrobutyricum in a fibrous-bed bioreactor |
| Q33215529 | Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells |
| Q35128381 | Resistant starch as a prebiotic and synbiotic: state of the art. |
| Q30054791 | Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics |
| Q35615383 | Sequencing and beyond: integrating molecular 'omics' for microbial community profiling |
| Q51732897 | Sodium butyrate induces cell death by autophagy and reactivates a tumor suppressor gene DIRAS1 in renal cell carcinoma cell line UOK146. |
| Q44789742 | Starch digestion, large-bowel fermentation and intestinal mucosal cell proliferation in rats treated with the alpha-glucosidase inhibitor acarbose |
| Q34936050 | Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults |
| Q37133422 | Targeting pro-invasive oncogenes with short chain fatty acid-hexosamine analogues inhibits the mobility of metastatic MDA-MB-231 breast cancer cells |
Search more.